Robert W. Baird Boosts Agilent Technologies (NYSE:A) Price Target to $156.00

Agilent Technologies (NYSE:A) had its target price hoisted by Robert W. Baird from $155.00 to $156.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the medical research company’s stock. Robert W. Baird’s price target would indicate a potential upside of 35.65% from the company’s current price.

A has been the subject of several other research reports. TD Cowen lowered their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. UBS Group lowered their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Morgan Stanley lowered their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Barclays lowered their target price on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Finally, Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a report on Thursday, February 26th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $163.07.

Agilent Technologies Price Performance

A stock opened at $115.01 on Tuesday. The company has a fifty day simple moving average of $114.84 and a two-hundred day simple moving average of $129.23. The firm has a market capitalization of $32.50 billion, a P/E ratio of 25.39, a price-to-earnings-growth ratio of 2.42 and a beta of 1.22. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. Agilent Technologies has a 52 week low of $107.07 and a 52 week high of $160.27.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). The firm had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.Agilent Technologies’s revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Analysts anticipate that Agilent Technologies will post 5.95 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of A. Brighton Jones LLC grew its position in shares of Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after buying an additional 270 shares during the last quarter. Jones Financial Companies Lllp grew its position in shares of Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares during the last quarter. Geneos Wealth Management Inc. grew its position in shares of Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares during the last quarter. Acadian Asset Management LLC grew its position in shares of Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after buying an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $273,000.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.